Precipio (PRPO) Stock


Company Profile

Price: $6.79

Market Cap: $10.07M

Exchange: NASDAQ

CEO: Mr. Ilan Danieli

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees: -0.00B

Headquarters: New Haven, CT

Website: Precipio

Business Summary

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.


Precipio Chart


Precipio News

Precipio Announces Employee Stock Option Plan Repricing
Precipio Announces Employee Stock Option Plan Repricing

NEW HAVEN, Conn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) announces the Company's repricing of a portion of its employee stock options to ensure their effectiveness as a retention tool for valuable employees.

  • globenewswire.com

    2024-09-06

Zacks Initiates Coverage of Precipio With Outperform Recommendation
Zacks Initiates Coverage of Precipio With Outperform Recommendation

Discover why Zacks rates Precipio as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore PRPO's approaching breakeven milestones, financial health, and market positioning in the cancer diagnostics space.

  • zacks.com

    2024-09-05

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript
Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO ) Q2 2024 Earnings Conference Call August 19, 2024 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Operator Welcome to the Precipio Second Quarter 2024 Shareholder Update Conference Call. All participants will be in a listen-only mode.

  • seekingalpha.com

    2024-08-19

Precipio Announces Q2-2024 Shareholder Update Call
Precipio Announces Q2-2024 Shareholder Update Call

NEW HAVEN, Conn., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2024 corporate update call on August 19th at 5:00 PM ET.

  • globenewswire.com

    2024-08-15

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Company's continued growth and improved cash position alleviates the need for capital raise in the foreseeable future Company's continued growth and improved cash position alleviates the need for capital raise in the foreseeable future

  • globenewswire.com

    2024-07-25

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Pathology Revenues in June exceed breakeven target and continue growth trend Pathology Revenues in June exceed breakeven target and continue growth trend

  • globenewswire.com

    2024-07-17

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

New Shareholders Meeting Date: Friday, June 21 at 9 a.m. Eastern Time New Shareholders Meeting Date: Friday, June 21 at 9 a.m. Eastern Time

  • globenewswire.com

    2024-06-13

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time.

  • globenewswire.com

    2024-06-12

Precipio Secures a short-term $500K Credit Facility
Precipio Secures a short-term $500K Credit Facility

Loan will supplement any temporary cashflow deficit related to cash collections delay due to Change Healthcare cybersecurity attack Loan will supplement any temporary cashflow deficit related to cash collections delay due to Change Healthcare cybersecurity attack

  • globenewswire.com

    2024-05-06



Precipio Earnings

This section highlight's Precipio's earnings, including earnings call transcripts, earnings surprises, and key dates.


Precipio Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q2 2024 2024-08-19 N/A N/A
Read Transcript Q3 2023 2023-11-20 N/A N/A
Read Transcript Q2 2023 2023-08-17 N/A N/A
Read Transcript Q1 2023 2023-05-18 N/A N/A
Read Transcript Q4 2022 2023-04-03 N/A N/A
Read Transcript Q3 2022 2022-11-14 N/A N/A
Read Transcript Q2 2022 2022-08-15 N/A N/A

Precipio Earnings Dates

When is the next earnings date for PRPO?

Date: 2024-11-11
Status: Unconfirmed
Time of Day: Before Market
Estimated EPS: $-

When was the last earnings date for PRPO?

Date: 2024-08-13
Fiscal Date Ending: 2024-06-30
EPS: $-0.83
Estimated EPS: $-
Revenue: $4.44M
Estimated Revenue: $4.33M

Upcoming PRPO Earnings

Date Estimated EPS Time of Day Status
2024-11-11 N/A Before Market Unconfirmed
2025-03-31 N/A -- Unconfirmed
2025-05-12 N/A -- Unconfirmed
2025-08-11 N/A -- Unconfirmed


Financial Statements

This section provides financial statements for Precipioincluding income statements, balance sheets, and cash flow statements, both annually and quarterly.


Annual Income Statement

Breakdown 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3.13M $6.09M $8.85M $9.41M $15.20M
Cost of Revenue $2.91M $4.94M $6.46M $6.90M $10.70M
Gross Profit $219.00K $1.15M $2.39M $2.51M $4.50M
Gross Profit Ratio 7.00% 18.88% 27.03% 26.67% 29.62%
Research and Development Expenses $1.20M $1.20M $1.30M $1.70M $1.70M
General and Administrative Expenses $8.32M $9.00M $10.61M $13.51M $10.32M
Selling and Marketing Expenses $100.00K $100.00K $100.00K $100.00K $100.00K
Selling General and Administrative Expenses $8.42M $9.10M $10.71M $13.61M $10.42M
Other Expenses $9.62M $10.30M $12.01M $15.31M $65.00K
Operating Expenses $9.62M $10.30M $12.01M $15.31M $12.12M
Cost and Expenses $12.53M $15.24M $18.46M $22.21M $22.82M
Interest Income $2.34M $470.00K $20.00K $12.00K $-
Interest Expense $473.00K $470.00K $20.00K $12.00K $18.00K
Depreciation and Amortization $1.35M $1.36M $1.44M $1.52M $1.52M
EBITDA $-6.43M $-6.66M $-8.17M $-11.28M $-6.10M
EBITDA Ratio -205.50% -109.24% -92.32% -119.82% -40.16%
Operating Income $-9.40M $-9.15M $-9.61M $-12.80M $-7.62M
Operating Income Ratio -300.74% -150.13% -108.63% -135.96% -50.14%
Total Other Income Expenses Net $-3.91M $-1.45M $1.10M $619.00K $1.77M
Income Before Tax $-13.31M $-10.60M $-8.52M $-12.18M $-5.85M
Income Before Tax Ratio -425.74% -173.97% -96.25% -129.39% -38.51%
Income Tax Expense $-70.00K $1.63M $33.00K $25.00K $1.35M
Net Income $-13.24M $-12.23M $-8.55M $-12.20M $-5.85M
Net Income Ratio -423.50% -200.76% -96.62% -129.65% -38.51%
EPS $-46.51 $-14.84 $-8.10 $-10.73 $-4.51
EPS Diluted $-46.51 $-14.84 $-8.10 $-10.73 $-4.51
Weighted Average Shares Outstanding 284.76K 823.85K 1.05M 1.14M 1.30M
Weighted Average Shares Outstanding Diluted 284.76K 823.85K 1.05M 1.14M 1.30M
SEC Filing Source Source Source Source Source

Quarterly Income Statement

Breakdown 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Revenue $784.00K $688.00K $1.22M $1.31M $1.63M $1.94M $1.82M $2.34M $2.25M $2.44M $2.45M $2.36M $2.21M $2.39M $2.82M $3.53M $3.74M $4.33M $3.43M $4.44M
Cost of Revenue $756.00K $707.00K $1.09M $1.14M $1.25M $1.46M $1.36M $1.59M $1.72M $1.79M $1.74M $1.59M $1.78M $1.79M $2.07M $2.16M $1.85M $2.69M $2.51M $3.02M
Gross Profit $28.00K $-19.00K $125.00K $171.00K $377.00K $477.00K $468.00K $751.00K $528.00K $645.00K $703.00K $773.00K $436.00K $598.00K $749.00K $1.37M $1.89M $1.64M $920.00K $1.42M
Gross Profit Ratio 3.57% -2.76% 10.28% 13.07% 23.17% 24.57% 25.66% 32.04% 23.51% 26.49% 28.73% 32.77% 19.68% 25.01% 26.59% 38.81% 50.43% 37.95% 26.81% 31.95%
Research and Development Expenses $- $2.79M $- $- $- $2.20M $- $- $- $2.30M $- $- $- $1.70M $- $- $- $2.70M $- $-
General and Administrative Expenses $- $4.56M $- $- $- $2.63M $- $- $- $3.45M $- $- $- $2.45M $- $- $- $2.40M $- $-
Selling and Marketing Expenses $- $100.00K $- $- $- $100.00K $- $- $- $100.00K $- $- $- $100.00K $- $- $- $100.00K $- $-
Selling General and Administrative Expenses $2.39M $-4.56M $2.33M $2.43M $2.81M $2.73M $2.34M $2.60M $2.68M $3.55M $5.13M $2.82M $3.28M $2.55M $3.77M $3.66M $3.33M $2.50M $2.99M $2.63M
Other Expenses $2.39M $2.67M $2.33M $153.00K $2.81M $2.73M $794.00K $2.88M $2.97M $3.55M $5.51M $3.21M $3.67M $2.92M $3.77M $3.66M $3.33M $2.87M $2.99M $2.92M
Operating Expenses $2.39M $2.67M $2.33M $2.43M $2.81M $2.73M $2.60M $2.88M $2.97M $3.55M $5.51M $3.21M $3.67M $2.92M $3.77M $3.66M $3.33M $2.50M $2.99M $2.63M
Cost and Expenses $3.15M $3.38M $3.42M $3.57M $4.06M $4.19M $3.96M $4.48M $4.68M $5.34M $7.26M $4.79M $5.44M $4.72M $5.84M $5.83M $5.19M $5.18M $5.51M $5.65M
Interest Income $- $- $- $- $- $- $- $- $- $- $- $- $6.00K $6.00K $4.00K $1.00K $- $-5.00K $- $-
Interest Expense $-97.00K $-175.00K $-713.00K $246.00K $-3.00K $- $7.00K $-1.00K $-6.00K $-6.00K $2.00K $2.00K $6.00K $6.00K $-4.00K $1.00K $-7.00K $6.00K $5.00K $11.00K
Depreciation and Amortization $347.00K $352.00K $354.00K $347.00K $327.00K $328.00K $332.00K $346.00K $363.00K $403.00K $382.00K $382.00K $384.00K $372.00K $382.00K $381.00K $384.00K $370.00K $378.00K $355.00K
EBITDA $-2.58M $-1.35M $-1.56M $-1.54M $-1.25M $-2.31M $-1.01M $-909.00K $-2.67M $-2.10M $-4.65M $-2.05M $-2.84M $-1.96M $-2.64M $-1.91M $-1.45M $-484.00K $-1.70M $-854.00K
EBITDA Ratio -328.95% -195.64% -128.29% -117.74% -76.71% -118.86% -55.43% -38.78% -118.74% -86.04% -189.99% -86.94% -128.31% -81.89% -93.86% -54.09% -38.74% -11.18% -49.42% -19.23%
Operating Income $-2.36M $-4.28M $-2.20M $-2.26M $-2.43M $-2.25M $-2.14M $-2.13M $-2.44M $-2.90M $-4.81M $-2.43M $-3.23M $-2.33M $-3.03M $-2.29M $-1.45M $-854.00K $-2.07M $-1.21M
Operating Income Ratio -301.40% -621.66% -181.17% -172.71% -149.48% -116.02% -117.16% -90.96% -108.59% -119.30% -196.53% -103.14% -145.78% -97.28% -107.42% -64.87% -38.74% -19.73% -60.43% -27.22%
Total Other Income Expenses Net $563.00K $-989.00K $-289.00K $-219.00K $-857.00K $383.00K $693.00K $-877.00K $591.00K $709.00K $225.00K $295.00K $56.00K $43.00K $-4.00K $-1.00K $-7.00K $1.78M $-5.00K $-11.00K
Income Before Tax $-1.90M $-3.85M $-3.21M $-2.23M $-3.29M $-1.87M $-1.45M $-3.01M $-1.85M $-2.20M $-4.58M $-2.14M $-3.17M $-2.28M $-3.03M $-2.29M $-1.46M $925.00K $-2.08M $-1.22M
Income Before Tax Ratio -241.96% -559.74% -263.57% -170.64% -202.34% -96.29% -79.55% -128.41% -82.55% -90.43% -187.33% -90.63% -143.25% -95.48% -107.56% -64.90% -38.92% 21.37% -60.58% -27.47%
Income Tax Expense $-466.00K $-70.00K $1.00M $17.00K $10.00K $-383.00K $1.00K $3.00K $6.00K $-6.00K $-219.00K $-289.00K $-50.00K $25.00K $8.00K $258.92K $-384.00K $376.00K $--0.00B $-
Net Income $-1.90M $-3.78M $-3.21M $-2.25M $-3.30M $-1.87M $-1.45M $-3.01M $-1.86M $-2.21M $-4.37M $-1.85M $-3.12M $-2.31M $-3.04M $-2.29M $-1.46M $925.00K $-2.08M $-1.22M
Net Income Ratio -241.96% -549.56% -263.57% -171.94% -202.95% -96.29% -79.61% -128.54% -82.81% -90.55% -178.38% -78.38% -140.99% -96.53% -107.85% -64.90% -38.92% 21.37% -60.58% -27.47%
EPS $-6.13 $-10.13 $-7.66 $-3.96 $-4.13 $-1.24 $-1.63 $-2.86 $-1.64 $-1.94 $-3.84 $-1.63 $-2.74 $-2.02 $-2.62 $-1.88 $-1.04 $0.65 $-1.46 $-0.83
EPS Diluted $-6.13 $-10.13 $-7.66 $-3.96 $-4.13 $-1.24 $-1.63 $-2.86 $-1.64 $-1.94 $-3.84 $-1.63 $-2.74 $-2.02 $-2.62 $-1.88 $-1.04 $0.65 $-1.46 $-0.83
Weighted Average Shares Outstanding 309.31K 373.37K 418.60K 567.65K 800.35K 1.51M 893.22K 1.05M 1.14M 1.14M 1.14M 1.14M 1.14M 1.14M 1.16M 1.22M 1.39M 1.42M 1.43M 1.46M
Weighted Average Shares Outstanding Diluted 309.31K 373.37K 418.60K 567.65K 800.35K 1.51M 893.22K 1.05M 1.14M 1.14M 1.14M 1.14M 1.14M 1.14M 1.16M 1.22M 1.39M 1.42M 1.43M 1.46M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Cash Equivalents $848.00K $2.66M $11.67M $3.44M $1.50M
Short Term Investments $- $- $- $- $-
Cash and Short Term Investments $848.00K $2.66M $11.67M $3.44M $1.50M
Net Receivables $574.00K $874.00K $697.00K $1.04M $1.30M
Inventory $184.00K $350.00K $564.00K $708.00K $384.00K
Other Current Assets $272.00K $324.00K $549.00K $521.00K $495.00K
Total Current Assets $1.88M $4.20M $13.48M $5.71M $3.68M
Property Plant Equipment Net $950.00K $787.00K $2.06M $1.90M $1.52M
Goodwill $- $- $- $- $-
Intangible Assets $16.66M $15.67M $14.72M $13.77M $12.82M
Goodwill and Intangible Assets $16.66M $15.67M $14.72M $13.77M $12.82M
Long Term Investments $- $- $- $- $-
Tax Assets $- $- $- $- $-
Other Non-Current Assets $25.00K $55.00K $179.00K $129.00K $76.00K
Total Non-Current Assets $17.63M $16.51M $16.96M $15.79M $14.42M
Other Assets $- $- $- $- $-0.00B
Total Assets $19.51M $20.71M $30.44M $21.50M $18.10M
Account Payables $1.94M $1.69M $1.86M $2.04M $622.00K
Short Term Debt $724.00K $921.00K $414.00K $616.00K $585.00K
Tax Payables $- $426.00K $148.00K $91.00K $287.00K
Deferred Revenue $35.00K $6.00K $18.00K $119.00K $110.00K
Other Current Liabilities $1.64M $2.04M $1.92M $1.58M $1.82M
Total Current Liabilities $4.33M $4.66M $4.21M $4.36M $3.14M
Long Term Debt $634.00K $570.00K $1.02M $776.00K $106.00K
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $-
Other Non-Current Liabilities $1.34M $1.32M $606.00K $- $425.00K
Total Non-Current Liabilities $1.97M $1.90M $1.62M $776.00K $531.00K
Other Liabilities $- $- $- $- $-
Total Liabilities $6.31M $6.55M $5.83M $5.14M $3.67M
Preferred Stock $- $- $- $- $-0.00B
Common Stock $79.00K $176.00K $227.00K $228.00K $14.00K
Retained Earnings $-60.94M $-71.56M $-80.09M $-92.30M $-98.15M
Accumulated Other Comprehensive Income Loss $- $- $- $- $-0.00B
Other Total Stockholders Equity $74.06M $85.52M $104.43M $108.37M $112.56M
Total Stockholders Equity $13.21M $14.13M $24.56M $16.30M $14.43M
Total Equity $13.21M $14.16M $24.60M $16.37M $14.43M
Total Liabilities and Stockholders Equity $19.51M $20.71M $30.44M $21.50M $18.10M
Minority Interest $- $27.00K $40.00K $65.00K $-
Total Liabilities and Total Equity $19.51M $20.71M $30.44M $21.50M $18.10M
Total Investments $- $- $- $- $-
Total Debt $1.36M $1.49M $1.43M $1.39M $1.12M
Net Debt $510.00K $-1.17M $-10.24M $-2.05M $-386.00K

Quarterly Balance Sheet

Breakdown 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Cash and Cash Equivalents $1.68M $848.00K $417.00K $353.00K $2.16M $2.66M $2.29M $15.70M $13.22M $11.67M $9.26M $7.47M $5.14M $3.44M $2.14M $2.57M $1.56M $1.50M $776.00K $1.28M
Short Term Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Cash and Short Term Investments $1.68M $848.00K $417.00K $353.00K $2.16M $2.66M $2.29M $15.70M $13.22M $11.67M $9.26M $7.47M $5.14M $3.44M $2.14M $2.57M $1.56M $1.50M $776.00K $1.28M
Net Receivables $693.00K $574.00K $883.00K $1.35M $1.09M $874.00K $625.00K $443.00K $570.00K $697.00K $1.15M $1.13M $955.00K $1.04M $858.00K $884.00K $1.48M $1.30M $906.00K $1.11M
Inventory $182.00K $184.00K $195.00K $233.00K $280.00K $350.00K $472.00K $556.00K $680.00K $564.00K $522.00K $642.00K $663.00K $708.00K $546.00K $537.00K $636.00K $384.00K $532.00K $653.00K
Other Current Assets $398.00K $272.00K $197.00K $75.00K $444.00K $324.00K $476.00K $280.00K $617.00K $549.00K $450.00K $364.00K $656.00K $521.00K $450.00K $354.00K $628.00K $495.00K $381.00K $325.00K
Total Current Assets $2.96M $1.88M $1.69M $2.02M $3.97M $4.20M $3.86M $16.98M $15.09M $13.48M $11.39M $9.61M $7.42M $5.71M $4.00M $4.35M $4.31M $3.68M $2.60M $3.36M
Property Plant Equipment Net $1.04M $950.00K $878.00K $850.00K $818.00K $787.00K $1.05M $1.28M $1.44M $2.06M $1.94M $1.98M $1.98M $1.90M $1.78M $1.73M $1.60M $1.52M $1.38M $1.55M
Goodwill $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Intangible Assets $18.51M $16.66M $16.40M $16.14M $15.90M $15.67M $15.43M $15.19M $14.96M $14.72M $14.48M $14.24M $14.01M $13.77M $13.53M $13.29M $13.06M $12.82M $12.58M $12.34M
Goodwill and Intangible Assets $18.51M $16.66M $16.40M $16.14M $15.90M $15.67M $15.43M $15.19M $14.96M $14.72M $14.48M $14.24M $14.01M $13.77M $13.53M $13.29M $13.06M $12.82M $12.58M $12.34M
Long Term Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Tax Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Non-Current Assets $25.00K $25.00K $25.00K $27.00K $27.00K $55.00K $80.00K $90.00K $116.00K $179.00K $167.00K $156.00K $144.00K $129.00K $116.00K $104.00K $88.00K $76.00K $64.00K $58.00K
Total Non-Current Assets $19.57M $17.63M $17.30M $17.02M $16.75M $16.51M $16.56M $16.56M $16.52M $16.96M $16.58M $16.37M $16.13M $15.79M $15.43M $15.12M $14.74M $14.42M $14.03M $13.95M
Other Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-0.00B $- $-
Total Assets $22.52M $19.51M $19.00M $19.03M $20.72M $20.71M $20.42M $33.54M $31.61M $30.44M $27.97M $25.98M $23.55M $21.50M $19.42M $19.47M $19.05M $18.10M $16.62M $17.32M
Account Payables $2.36M $1.94M $2.19M $2.08M $1.83M $1.69M $1.97M $1.82M $1.57M $1.86M $2.32M $2.56M $2.13M $2.04M $2.19M $2.40M $2.51M $622.00K $905.00K $855.00K
Short Term Debt $763.00K $724.00K $2.72M $647.00K $786.00K $921.00K $352.00K $416.00K $363.00K $414.00K $383.00K $392.00K $729.00K $616.00K $502.00K $407.00K $699.00K $585.00K $410.00K $562.00K
Tax Payables $- $- $- $- $- $426.00K $- $397.00K $390.00K $148.00K $94.00K $85.00K $84.00K $91.00K $137.00K $114.00K $136.00K $287.00K $196.00K $181.00K
Deferred Revenue $19.00K $35.00K $- $- $48.00K $6.00K $101.00K $58.00K $148.00K $18.00K $21.00K $13.00K $13.00K $119.00K $124.00K $17.00K $29.00K $110.00K $193.00K $260.00K
Other Current Liabilities $1.50M $1.64M $1.83M $1.95M $1.80M $2.04M $1.76M $1.34M $1.56M $1.92M $1.67M $1.43M $1.54M $1.58M $1.69M $1.90M $2.21M $1.82M $1.82M $2.92M
Total Current Liabilities $4.64M $4.33M $6.74M $4.68M $4.47M $4.66M $4.18M $3.64M $3.65M $4.21M $4.39M $4.39M $4.41M $4.36M $4.50M $4.72M $5.45M $3.14M $3.33M $4.59M
Long Term Debt $703.00K $634.00K $569.00K $953.00K $758.00K $570.00K $369.00K $437.00K $411.00K $1.02M $940.00K $933.00K $855.00K $776.00K $697.00K $660.00K $597.00K $106.00K $99.00K $92.00K
Deferred Revenue Non-Current $1.77M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $70.00K $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Non-Current Liabilities $45.00K $1.34M $402.00K $774.00K $1.63M $1.32M $1.31M $2.21M $1.63M $606.00K $384.00K $87.00K $28.00K $- $- $- $- $425.00K $424.00K $516.00K
Total Non-Current Liabilities $2.59M $1.97M $971.00K $1.73M $2.39M $1.90M $1.68M $2.64M $2.04M $1.62M $1.32M $1.02M $883.00K $776.00K $697.00K $660.00K $597.00K $531.00K $523.00K $608.00K
Other Liabilities $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $7.23M $6.31M $7.71M $6.41M $6.86M $6.55M $5.87M $6.28M $5.69M $5.83M $5.72M $5.41M $5.29M $5.14M $5.20M $5.38M $6.05M $3.67M $3.85M $5.20M
Preferred Stock $- $- $- $- $- $- $-0.00B $- $-0.00B $- $- $- $-0.00B $- $- $-0.00B $- $-0.00B $- $-
Common Stock $71.00K $79.00K $95.00K $146.00K $167.00K $176.00K $181.00K $227.00K $227.00K $227.00K $227.00K $227.00K $228.00K $228.00K $233.00K $275.00K $14.00K $14.00K $14.00K $14.00K
Retained Earnings $-57.16M $-60.94M $-64.14M $-66.39M $-69.69M $-71.56M $-73.02M $-76.03M $-77.89M $-80.09M $-84.68M $-86.83M $-90.01M $-92.30M $-95.33M $-97.62M $-99.08M $-98.15M $-100.23M $-101.45M
Accumulated Other Comprehensive Income Loss $- $-791.00K $- $- $- $- $-0.00B $- $--0.00B $- $- $- $-0.00B $- $- $-0.00B $- $-0.00B $- $-
Other Total Stockholders Equity $72.38M $74.86M $75.33M $78.86M $83.36M $85.52M $87.36M $103.03M $103.54M $104.43M $106.66M $107.11M $107.97M $108.37M $109.25M $111.37M $112.00M $112.56M $112.99M $113.55M
Total Stockholders Equity $15.29M $13.21M $11.29M $12.61M $13.83M $14.13M $14.53M $27.23M $25.88M $24.56M $22.21M $20.51M $18.20M $16.30M $14.16M $14.03M $12.94M $14.43M $12.77M $12.12M
Total Equity $15.29M $13.21M $11.29M $12.63M $13.86M $14.16M $14.56M $27.26M $25.92M $24.60M $22.25M $20.57M $18.25M $16.37M $14.22M $14.09M $13.00M $14.43M $12.77M $12.12M
Total Liabilities and Stockholders Equity $22.52M $19.51M $19.00M $19.03M $20.72M $20.71M $20.42M $33.54M $31.61M $30.44M $27.97M $25.98M $23.55M $21.50M $19.42M $19.47M $19.05M $18.10M $16.62M $17.32M
Minority Interest $- $- $- $17.00K $27.00K $27.00K $28.00K $31.00K $37.00K $40.00K $46.00K $52.00K $58.00K $65.00K $65.00K $65.00K $65.00K $- $- $-
Total Liabilities and Total Equity $22.52M $19.51M $19.00M $19.03M $20.72M $20.71M $20.42M $33.54M $31.61M $30.44M $27.97M $25.98M $23.55M $21.50M $19.42M $19.47M $19.05M $18.10M $16.62M $17.32M
Total Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Debt $1.47M $1.36M $3.29M $1.60M $1.54M $1.49M $721.00K $853.00K $774.00K $1.43M $1.32M $1.32M $1.58M $1.39M $1.20M $1.07M $1.30M $1.12M $933.00K $1.17M
Net Debt $-217.00K $510.00K $2.87M $1.25M $-614.00K $-1.17M $-1.56M $-14.85M $-12.45M $-10.24M $-7.94M $-6.15M $-3.56M $-2.05M $-942.00K $-1.51M $-266.00K $-386.00K $157.00K $-109.00K

Annual Cash Flow Statement

Breakdown 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income $-13.24M $-10.60M $-8.52M $-12.18M $-5.85M
Depreciation and Amortization $1.41M $1.36M $1.44M $1.52M $1.52M
Deferred Income Tax $3.70M $2.50M $-1.21M $- $328.00K
Stock Based Compensation $668.00K $703.00K $2.03M $3.80M $1.74M
Change in Working Capital $-2.49M $-1.63M $-395.00K $-643.00K $606.00K
Accounts Receivables $-850.00K $-1.64M $327.00K $-745.00K $-483.00K
Inventory $13.00K $-166.00K $-214.00K $-144.00K $324.00K
Accounts Payables $-1.88M $-243.00K $112.00K $165.00K $-169.00K
Other Working Capital $230.00K $414.00K $-620.00K $81.00K $934.00K
Other Non Cash Items $810.00K $243.00K $225.00K $-221.00K $-1.89M
Net Cash Provided by Operating Activities $-9.14M $-7.43M $-6.58M $-7.72M $-3.56M
Investments in Property Plant and Equipment $-55.00K $-151.00K $-682.00K $-277.00K $-126.00K
Acquisitions Net $- $55.00K $- $- $-
Purchases of Investments $- $- $- $- $-
Sales Maturities of Investments $- $- $- $- $-
Other Investing Activities $- $55.00K $- $- $-
Net Cash Used for Investing Activities $-55.00K $-96.00K $-682.00K $-277.00K $-126.00K
Debt Repayment $-1.58M $-378.00K $-170.00K $-365.00K $-503.00K
Common Stock Issued $8.20M $8.93M $16.61M $129.00K $2.25M
Common Stock Repurchased $-1.00K $- $- $- $-
Dividends Paid $- $- $- $- $-
Other Financing Activities $8.08M $787.00K $16.44M $11.00K $-423.00K
Net Cash Used Provided by Financing Activities $9.66M $9.34M $16.27M $-225.00K $1.74M
Effect of Forex Changes on Cash $- $- $- $- $-
Net Change in Cash $467.00K $1.81M $9.01M $-8.22M $-1.94M
Cash at End of Period $848.00K $2.66M $11.67M $3.44M $1.50M
Cash at Beginning of Period $381.00K $848.00K $2.66M $11.67M $3.44M
Operating Cash Flow $-9.14M $-7.43M $-6.58M $-7.72M $-3.56M
Capital Expenditure $-55.00K $-151.00K $-682.00K $-277.00K $-126.00K
Free Cash Flow $-9.20M $-7.58M $-7.26M $-8.00M $-3.69M

Quarterly Cash Flow Statement

Breakdown 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Net Income $-1.90M $-3.78M $-3.21M $-2.23M $-3.29M $-1.87M $-1.45M $-3.01M $-1.85M $-2.20M $-4.58M $-2.14M $-3.17M $-2.28M $-3.03M $-2.29M $-1.46M $925.00K $-2.08M $-1.22M
Depreciation and Amortization $347.00K $352.00K $354.00K $347.00K $327.00K $328.00K $332.00K $346.00K $363.00K $403.00K $382.00K $382.00K $384.00K $372.00K $382.00K $381.00K $384.00K $370.00K $378.00K $355.00K
Deferred Income Tax $-302.00K $1.42M $557.00K $655.00K $1.28M $8.00K $-388.00K $794.00K $-684.00K $-935.00K $- $- $- $- $- $- $51.00K $-1.55M $- $-
Stock Based Compensation $148.00K $213.00K $168.00K $161.00K $212.00K $162.00K $437.00K $363.00K $510.00K $569.00K $2.23M $451.00K $722.00K $396.00K $450.00K $352.00K $366.00K $567.00K $357.00K $550.00K
Change in Working Capital $-452.00K $-274.00K $-127.00K $-557.00K $-946.00K $-4.00K $-383.00K $-235.00K $-482.00K $705.00K $-220.00K $-132.00K $-193.00K $-98.00K $611.00K $245.00K $-243.00K $-7.00K $594.00K $768.00K
Accounts Receivables $-71.00K $-123.00K $-577.00K $-809.00K $-151.00K $-102.00K $-39.00K $282.00K $-21.00K $105.00K $-535.00K $-60.00K $92.00K $-242.00K $166.00K $-138.00K $-650.00K $139.00K $312.00K $-230.00K
Inventory $7.00K $-2.00K $-11.00K $-38.00K $-47.00K $-70.00K $-122.00K $-84.00K $-124.00K $116.00K $42.00K $-120.00K $-21.00K $-45.00K $162.00K $9.00K $-99.00K $252.00K $-148.00K $-121.00K
Accounts Payables $-308.00K $-260.00K $250.00K $-103.00K $-254.00K $-136.00K $194.00K $-113.00K $-237.00K $268.00K $448.00K $244.00K $-457.00K $-70.00K $141.00K $212.00K $115.00K $-637.00K $283.00K $-50.00K
Other Working Capital $-80.00K $111.00K $211.00K $393.00K $-494.00K $304.00K $-416.00K $-320.00K $-100.00K $216.00K $-175.00K $-196.00K $193.00K $259.00K $142.00K $162.00K $391.00K $239.00K $147.00K $1.17M
Other Non Cash Items $42.00K $-67.00K $664.00K $-347.00K $2.00K $-76.00K $164.00K $-17.00K $18.00K $60.00K $-144.00K $-209.00K $19.00K $113.00K $12.00K $113.00K $1.00K $-188.00K $749.00K $1.71M
Net Cash Provided by Operating Activities $-2.11M $-2.14M $-1.59M $-1.97M $-2.42M $-1.45M $-1.29M $-1.76M $-2.13M $-1.40M $-2.33M $-1.65M $-2.24M $-1.50M $-1.57M $-1.20M $-896.00K $114.00K $-667.00K $500.00K
Investments in Property Plant and Equipment $-19.00K $-6.00K $-24.00K $-41.00K $-56.00K $-30.00K $-185.00K $-136.00K $-303.00K $-58.00K $-10.00K $-96.00K $-119.00K $-52.00K $-22.00K $-32.00K $-23.00K $-49.00K $- $-70.00K
Acquisitions Net $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Purchases of Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Sales Maturities of Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Investing Activities $- $- $- $55.00K $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Net Cash Used for Investing Activities $-19.00K $-6.00K $-24.00K $14.00K $-56.00K $-30.00K $-185.00K $-136.00K $-303.00K $-58.00K $-10.00K $-96.00K $-119.00K $-52.00K $-22.00K $-32.00K $-23.00K $-49.00K $- $-70.00K
Debt Repayment $-114.00K $-146.00K $-168.00K $-149.00K $-32.00K $-29.00K $-26.00K $-37.00K $-49.00K $-58.00K $-63.00K $-46.00K $-109.00K $-147.00K $-145.00K $-141.00K $-92.00K $-125.00K $-126.00K $-62.00K
Common Stock Issued $2.76M $1.46M $1.35M $1.26M $4.31M $2.01M $1.26M $15.35M $3.00K $-16.21M $- $- $129.00K $- $438.00K $1.81M $- $- $67.00K $11.00K
Common Stock Repurchased $2.76M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Dividends Paid $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Financing Activities $2.76M $1.46M $1.35M $787.00K $4.31M $2.01M $1.10M $15.34M $-3.00K $2.00K $-7.00K $-46.00K $11.00K $-147.00K $293.00K $1.67M $- $173.00K $-109.00K $-
Net Cash Used Provided by Financing Activities $2.65M $1.31M $1.18M $1.90M $4.28M $1.98M $1.07M $15.30M $-52.00K $-56.00K $-63.00K $-46.00K $31.00K $-147.00K $293.00K $1.67M $-92.00K $-125.00K $-59.00K $73.00K
Effect of Forex Changes on Cash $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Net Change in Cash $514.00K $-835.00K $-431.00K $-64.00K $1.80M $498.00K $-370.00K $13.41M $-2.48M $-1.55M $-2.41M $-1.79M $-2.33M $-1.70M $-1.30M $432.00K $-1.01M $-60.00K $-726.00K $503.00K
Cash at End of Period $1.68M $848.00K $417.00K $353.00K $2.16M $2.66M $2.29M $15.70M $13.22M $11.67M $9.26M $7.47M $5.14M $3.44M $2.14M $2.57M $1.56M $1.50M $776.00K $1.28M
Cash at Beginning of Period $1.17M $1.68M $848.00K $417.00K $353.00K $2.16M $2.66M $2.29M $15.70M $13.22M $11.67M $9.26M $7.47M $5.14M $3.44M $2.14M $2.57M $1.56M $1.50M $776.00K
Operating Cash Flow $-2.11M $-2.14M $-1.59M $-1.97M $-2.42M $-1.45M $-1.29M $-1.76M $-2.13M $-1.40M $-2.33M $-1.65M $-2.24M $-1.50M $-1.57M $-1.20M $-896.00K $114.00K $-667.00K $500.00K
Capital Expenditure $-19.00K $-6.00K $-24.00K $-41.00K $-56.00K $-30.00K $-185.00K $-136.00K $-303.00K $-58.00K $-10.00K $-96.00K $-119.00K $-52.00K $-22.00K $-32.00K $-23.00K $-49.00K $- $-70.00K
Free Cash Flow $-2.13M $-2.15M $-1.61M $-2.01M $-2.48M $-1.48M $-1.47M $-1.90M $-2.43M $-1.46M $-2.34M $-1.74M $-2.36M $-1.55M $-1.60M $-1.23M $-919.00K $65.00K $-667.00K $430.00K

Precipio Dividends

Understand Precipio's dividend history, dividend yield, payout ratio, and more.

Dividend Yield

-

Dividend Payout Ratio

-

Dividend Paid & Capex Coverage Ratio

28.25x



Precipio Dividend History

Dividend Adjusted Dividend Date Record Date Payment Date Declaration Date

Valuation

Analyze the market cap, enterprise value, and valuation metrics for Precipio.

Market Cap & Enterprise Value

Market Cap: $10.07M

Enterprise Value: $8.05M

Valuation Ratios

P/E Ratio: -1.44

P/B Ratio: 0.58

P/CF Ratio: -2.37

Valuation Multiples

E/V to Sales: 0.53

E/V to EBITDA: -1.32

Market Cap & Enterprise Value

Market capitalization and enterprise value provide an understanding of a company's market value and total value, respectively.

  • Market Cap: The total market value of a company's outstanding shares of stock. It represents the company's equity value and is calculated by multiplying the current share price by the total number of outstanding shares.
  • Enterprise Value (EV): A measure of a company's total value, often seen as a more comprehensive alternative to equity market capitalization. It includes market cap plus debt, minority interest, and preferred shares, minus total cash and cash equivalents.

Valuation Ratios

Valuation ratios are used to evaluate the value of a company compared to its earnings, book value, and cash flow.

  • P/E Ratio: Price to Earnings Ratio, indicating how much investors are willing to pay for a dollar of earnings.
  • P/B Ratio: Price to Book Ratio, comparing the company's market value to its book value. A lower ratio may indicate undervaluation.
  • P/CF Ratio: Price to Cash Flow Ratio, evaluating the market value relative to the operating cash flow. A lower ratio can signal a more attractive investment.

Valuation Multiples

Valuation multiples help assess a company's value relative to its revenue and earnings.

  • EV to Sales: Enterprise Value to Sales, comparing the enterprise value to sales revenue. A lower ratio can indicate a more attractive investment.
  • EV to EBITDA: Enterprise Value to EBITDA, comparing the enterprise value to earnings before interest, taxes, depreciation, and amortization. A lower ratio suggests a company may be undervalued.

Precipio Growth

View income_statement_chart2_annual_data financial growth metrics for Precipio, including income statement, balance sheet, and cash flow growth.

Income Growth

Revenue Growth: 29.40%

Operating Income Growth: 41.71%

Cash Flow Growth

Net Income Growth: 41.32%

Free Cash Flow Growth: 164.47%

Balance Sheet Growth

Total Assets Growth: 4.17%

Total Liabilities Growth: 35.14%

Income Growth

This section highlights key metrics related to income growth, showing how the company’s revenue and operating income have changed over time:

  • Revenue Growth: The increase in a company's sales over time. It is a measure of how quickly the company is growing its revenue. This chart shows the historical trend of revenue growth.
  • Operating Income Growth: The growth rate of a company's operating income, which is the income earned from its normal business operations. This chart helps to assess the company's operational efficiency and profitability growth over time.

Cash Flow Growth

This section highlights key metrics on the company's cash flow growth, reflecting changes in net income and free cash flow over time.

  • Net Income Growth: The increase in a company's net profit over time. It reflects the company's ability to increase its profitability. This chart provides insight into how the company's bottom line has grown.
  • Free Cash Flow Growth: The growth in a company's free cash flow, which is the cash generated by the company after accounting for capital expenditures. This chart is important for understanding the company's financial flexibility and ability to fund operations and growth.

Balance Sheet Growth

This section highlight key metrics related to balance sheet growth, which indicate how the company’s total assets and liabilities have changed over time:

  • Total Assets Growth: The rate at which a company's total assets are increasing over time. This chart indicates how the company's asset base is expanding, which can be a sign of growth and investment in future operations.
  • Total Liabilities Growth: The rate at which a company's total liabilities are increasing over time. This chart helps to assess the company's financial leverage and risk over time.

Peers: Medical - Diagnostics & Research

This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.

Company Market Cap Price EPS P/E Ratio P/B Ratio
BDSX Logo
Biodesix, Inc.
BDSX
$245.35M $1.69 $-0.64 $-2.90 $32.99
SERA Logo
Sera Prognostics, Inc.
SERA
$233.61M $7.21 $-1.16 $-5.15 $2.66
APDN Logo
Applied DNA Sciences, Inc.
APDN
$3.81M $0.37 $-15.21 $-1.59 $3.20
OLK Logo
Olink Holding AB (publ)
OLK
$3.24B $26.08 $-0.26 $-98.51 $6.20
CDNA Logo
CareDx, Inc
CDNA
$1.63B $30.91 $-3.54 $-3.39 $2.47
CSTL Logo
Castle Biosciences, Inc.
CSTL
$814.08M $29.35 $-2.14 $-10.06 $1.48
TWST Logo
Twist Bioscience Corporation
TWST
$2.54B $43.34 $-3.60 $-5.63 $1.85
NTRA Logo
Natera, Inc.
NTRA
$16.06B $129.84 $-3.78 $-16.57 $9.41
HTGM Logo
HTG Molecular Diagnostics, Inc.
HTGM
$1.06M $0.48 $-24.28 $-0.16 $0.66
GTH Logo
Genetron Holdings Limited
GTH
$127.29M $4.03 $-9.53 $-2.43 $3.94
BIAF Logo
bioAffinity Technologies, Inc.
BIAF
$24.55M $1.82 $-0.91 $-1.62 $2.65
PMD Logo
Psychemedics Corporation
PMD
$13.45M $2.31 $-0.72 $-4.09 $2.55
GENE Logo
Genetic Technologies Limited
GENE
$6.94M $0.73 $-0.10 $-21.22 $139.33
MDXH Logo
MDxHealth SA
MDXH
$94.58M $2.00 $-1.66 $-2.37 $14.16
STRR Logo
Star Equity Holdings, Inc.
STRR
$13.31M $4.12 $-0.10 $-52.83 $1.25
XGN Logo
Exagen Inc.
XGN
$52.16M $3.00 $-1.34 $-1.49 $1.55
BNR Logo
Burning Rock Biotech Limited
BNR
$38.01M $3.71 $-6.38 $-10.77 $9.16
LMDX Logo
LumiraDx Limited
LMDX
$- $0.02 $-1.59 $-0.56 $-2.27

More metrics for Precipio

Access more key metrics, financials, ratios, and more with the links below.